RISE研究中糖耐量受损或新诊断2型糖尿病青少年与成人血糖恶化的基线预测因素
该研究基于RISE研究,纳入91名青少年和267名成人糖耐量受损或新诊断2型糖尿病患者,随机接受不同降糖治疗,通过基线高糖钳夹和口服葡萄糖耐量试验寻找血糖恶化(HbA1c较基线升高≥0.5%)的基线预测因素。结果发现青少年血糖恶化发生率高于成人,β细胞反应降低是两组共同预测因素,青少年中高血糖指标、成人中胰岛素抵抗指标分别预测恶化。
要点
- 青少年血糖恶化发生率在12个月和21个月均高于成人(17.8% vs 7.5%,36% vs 20%)。
- 基线钳夹法β细胞反应降低预测两组12个月和21个月血糖恶化。
- 青少年中基线HbA1c、2小时血糖和空腹血糖较高预测血糖恶化,成人中胰岛素敏感性降低预测恶化。
核心结论
- 糖耐量受损或新诊断2型糖尿病青少年血糖恶化较成人更常见。
- 两组中基线β细胞反应降低均预测血糖恶化,青少年中高血糖指标、成人中胰岛素抵抗指标分别预测恶化。
研究设计与样本
- RISE研究:91名青少年(10-19岁)随机接受12个月二甲双胍或3个月甘精胰岛素后9个月二甲双胍;267名成人随机接受二甲双胍、甘精胰岛素后二甲双胍、利拉鲁肽联合二甲双胍或安慰剂治疗12个月。
- 所有参与者在基线、第6个月、第12个月及停药后第15个月和第21个月进行高糖钳夹和3小时口服葡萄糖耐量试验。
- 采用Cox模型识别血糖恶化(HbA1c较基线升高≥0.5%)的基线预测因素。
主要发现
- 第12个月血糖恶化在青少年中占17.8%,成人中占7.5%(P=0.008);第21个月分别为36%和20%(P=0.002)。
- 青少年中血糖恶化无治疗差异;成人中第12个月利拉鲁肽联合二甲双胍较安慰剂血糖恶化更少(风险比0.21,95%CI 0.05-0.96,P=0.044)。
- 两组中基线钳夹法β细胞反应较低预测第12个月和第21个月血糖恶化(P<0.01);基线OGTT法β细胞反应较低预测第21个月恶化(P<0.05)。
- 青少年中基线HbA1c和2小时血糖较高预测第12个月和第21个月恶化,空腹血糖较高预测第21个月恶化(P<0.05)。
- 成人中基线钳夹法和OGTT法胰岛素敏感性较低预测第12个月和第21个月恶化(P<0.05)。
临床怎么用
- 对糖耐量受损或新诊断2型糖尿病青少年应更密切监测血糖恶化,因其发生率高于成人。
- 基线β细胞功能评估有助于识别两组中血糖恶化高风险个体。
- 青少年中需关注基线高血糖水平,成人中需评估胰岛素敏感性以预测血糖恶化风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To identify predictors of glycemic worsening among youth and adults with impaired glucose tolerance (IGT) or recently diagnosed type 2 diabetes in the Restoring Insulin Secretion (RISE) Study. RESEARCH DESIGN AND METHODS: A total of 91 youth (10-19 years) were randomized 1:1 to 12 months of metformin (MET) or 3 months of glargine, followed by 9 months of metformin (G-MET), and 267 adults were randomized to MET, G-MET, liraglutide plus MET (LIRA+MET), or placebo for 12 months. All participants underwent a baseline hyperglycemic clamp and a 3-h oral glucose tolerance test (OGTT) at baseline, month 6, month 12, and off treatment at month 15 and month 21. Cox models identified baseline predictors of glycemic worsening (HbA1c increase ≥0.5% from baseline). RESULTS: Glycemic worsening occurred in 17.8% of youth versus 7.5% of adults at month 12 (P = 0.008) and in 36% of youth versus 20% of adults at month 21 (P = 0.002). In youth, glycemic worsening did not differ by treatment. In adults, month 12 glycemic worsening was less on LIRA+MET versus placebo (hazard ratio 0.21, 95% CI 0.05-0.96, P = 0.044). In both age-groups, lower baseline clamp-derived β-cell responses predicted month 12 and month 21 glycemic worsening (P < 0.01). Lower baseline OGTT-derived β-cell responses predicted month 21 worsening (P < 0.05). In youth, higher baseline HbA1c and 2-h glucose predicted month 12 and month 21 glycemic worsening, and higher fasting glucose predicted month 21 worsening (P < 0.05). In adults, lower clamp- and OGTT-derived insulin sensitivity predicted month 12 and month 21 worsening (P < 0.05). CONCLUSIONS: Glycemic worsening was more common among youth than adults with IGT or recently diagnosed type 2 diabetes, predicted by lower baseline β-cell responses in both groups, hyperglycemia in youth, and insulin resistance in adults.
引用
- Sam S, Edelstein SL, Arslanian SA, et al. Baseline Predictors of Glycemic Worsening in Youth and Adults With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes in the Restoring Insulin Secretion (RISE) Study. Diabetes Care. 2021. PMID: 34131048. doi:10.2337/dc21-0027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。